Zoetis | ZTS - Ebitda

Stock Price
116.87
Daily Change
0.81 0.70%
Monthly
0.14%
Yearly
-23.85%
Q2 Forecast
114.37

Zoetis reported $1.04B in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
Align Technology USD 183.84M 19.77M Sep/2025
Bayer EUR 1.97B 457M Dec/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Charles River Laboratories USD 258.06M 24.83M Dec/2025
Coherus Biosciences USD -43.33M 4.7M Sep/2025
Dentsply International USD 135M 32M Dec/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Henry Schein USD 291M 4M Dec/2025
Idexx Laboratories USD 391.47M 17.97M Sep/2025
Illumina USD 332M 12M Sep/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
J&J USD 7.19B 2.32B Dec/2025
Laboratory Of America USD 588.1M 24.1M Dec/2025
Merck USD 8.39B 1.97B Sep/2025
Neogen USD 48.2M 546K Dec/2025
Pacira USD 38.71M 10.65M Dec/2025
Perrigo USD 258.8M 37.3M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Quest Diagnostics USD 557M 20M Mar/2026
Sanofi EUR 3.31B 3.65B Mar/2026
Sanofi EUR 5.66B 3.77B Sep/2025
Zoetis USD 1.04B 87M Sep/2025